Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects With Overt Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2015050473
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Association Between Pro12Ala Polymorphism and Albuminuria in Type‐2 Diabetic Nephropathy

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2020English

Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2011English

Interleukin-17a Blockade Reduces Albuminuria and Kidney Injury in an Accelerated Model of Diabetic Nephropathy

Kidney International
Nephrology
2019English

Association Between Serum Bilirubin and Albuminuria in Type 2 Diabetes Mellitus and Diabetic Nephropathy

International Journal of Clinical Biochemistry and Research
2018English

Urinary Biomarkers for Early Diabetic Nephropathy: Beyond Albuminuria

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2014English

Aliskiren in Combination With Losartan Reduces Albuminuria Independent of Baseline Blood Pressure in Patients With Type 2 Diabetes and Nephropathy

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2011English

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

Kidney International Reports
Nephrology
2019English

Inhibition of RAS in Diabetic Nephropathy

International Journal of Nephrology and Renovascular Disease
Nephrology
2015English

Inhibition of Type-5 Phosphodiesterase: Promising Therapy for Pulmonary Hypertension

Internal Medicine
Internal MedicineMedicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy